Resultados de procura - Benjamin Heidrich
- Mostrando 1 - 11 Resultados de 11
-
1
Uncovering the trimethylamine-producing bacteria of the human gut microbiota por Silke Rath, Benjamin Heidrich, Dietmar H. Pieper, Marius Vital
Publicado 2017-05-01
Artigo -
2
Clinical significance of transjugular liver biopsy in acute liver failure – a real-world analysis por Bahar Nalbant, Thorben Pape, Andrea Schneider, Benjamin Seeliger, Paul Schirmer, Benjamin Heidrich, Richard Taubert, Heiner Wedemeyer, Henrike Lenzen, Klaus Stahl
Publicado 2024-08-01
Artigo -
3
Prevention of peri-interventional hypothermia during endoscopic retrograde cholangiopancreatography using a forced-air heating system por Klaus Stahl, Eloise Schuette, Paul Schirmer, Jan Fuge, Anna-Lena Weber, Benjamin Heidrich, Andrea Schneider, Thorben Pape, Terence Krauss, Heiner Wedemeyer, Henrike Lenzen
Publicado 2024-01-01
Artigo -
4
HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta por Lisa Sandmann, Cihan Yurdaydin, Katja Deterding, Benjamin Heidrich, Svenja Hardtke, Patrick Lehmann, Birgit Bremer, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer, Benjamin Maasoumy, HIDIT‐II Study Group
Publicado 2022-03-01
Artigo -
5
The novel immunosuppressive protein kinase C inhibitor sotrastaurin has no pro-viral effects on the replication cycle of hepatitis B or C virus. por Thomas von Hahn, Andreas Schulze, Ivan Chicano Wust, Benjamin Heidrich, Thomas Becker, Eike Steinmann, Fabian A Helfritz, Katrin Rohrmann, Stephan Urban, Michael P Manns, Thomas Pietschmann, Sandra Ciesek
Publicado 2011-01-01
Artigo -
6
Dulaglutide Alone and in Combination with Empagliflozin Attenuate Inflammatory Pathways and Microbiome Dysbiosis in a Non-Diabetic Mouse Model of NASH por Katharina Luise Hupa-Breier, Janine Dywicki, Björn Hartleben, Freya Wellhöner, Benjamin Heidrich, Richard Taubert, Young-Seon Elisabeth Mederacke, Maren Lieber, Konstantinos Iordanidis, Michael P. Manns, Heiner Wedemeyer, Matthias Hardtke-Wolenski, Elmar Jaeckel
Publicado 2021-03-01
Artigo -
7
Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting. por Steffen B Wiegand, Benjamin Heidrich, Simone Susser, Magdalena Rogalska-Taranta, Jörg Petersen, Klaus H W Böker, Natalia Grigorian, Ralph Link, Uwe Naumann, Christine John, Stefan Lueth, Peter Malfertheiner, Michael P Manns, Heiner Wedemeyer, Christoph Sarrazin, Markus Cornberg
Publicado 2015-01-01
Artigo -
8
Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective,... por Benjamin Heidrich, Hans-Jörg Cordes, Hartwig Klinker, Bernd Möller, Uwe Naumann, Martin Rössle, Michael R Kraus, Klaus H Böker, Christoph Roggel, Marcus Schuchmann, Albrecht Stoehr, Andreas Trein, Svenja Hardtke, Andrea Gonnermann, Armin Koch, Heiner Wedemeyer, Michael P Manns, Markus Cornberg
Publicado 2015-01-01
Artigo -
9
BISCIT: Biliary interventions in critically ill patients with secondary sclerosing cholangitis—a study protocol for a multicenter, randomized, controlled parallel group trial por Klaus Stahl, Friederike Klein, Torsten Voigtländer, Anika Großhennig, Thorsten Book, Tobias Müller, Alexander Wree, Armin Kuellmer, Jochen Weigt, Alexander Dechene, Edris Wedi, Arne Kandulski, Christian M. Lange, Dennis Holzwart, Dorothee von Witzendorff, Kristina I. Ringe, Heiner Wedemeyer, Benjamin Heidrich, for the BISCIT Study group
Publicado 2023-03-01
Artigo -
10
Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA. por Benjamin Heidrich, Steffen B Wiegand, Peter Buggisch, Holger Hinrichsen, Ralph Link, Bernd Möller, Klaus H W Böker, Gerlinde Teuber, Hartwig Klinker, Elmar Zehnter, Uwe Naumann, Heiner W Busch, Benjamin Maasoumy, Undine Baum, Svenja Hardtke, Michael P Manns, Heiner Wedemeyer, Jörg Petersen, Markus Cornberg, HepNet Study Group
Publicado 2014-01-01
Artigo -
11
Anti-HDV IgM as a marker of disease activity in hepatitis delta. por Anika Wranke, Benjamin Heidrich, Stefanie Ernst, Beatriz Calle Serrano, Florin Alexandru Caruntu, Manuela Gabriela Curescu, Kendal Yalcin, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, George V Papatheodoridis, Birgit Bremer, Judith Stift, Jan Grabowski, Janina Kirschner, Kerstin Port, Markus Cornberg, Christine S Falk, Hans-Peter Dienes, Svenja Hardtke, Michael P Manns, Cihan Yurdaydin, Heiner Wedemeyer, HIDIT-2 Study Group
Publicado 2014-01-01
Artigo